Related Experiment Videos
Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology
Iva Navratilova1, Marianna Dioszegi, David G Myszka
1Center for Biomolecular Interaction Analysis, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Analytical Biochemistry
|June 10, 2006
Summary
This study demonstrates that solubilized chemokine receptors CXCR4 and CCR5 retain native binding properties for ligands and small molecules. This validates biosensor assays for drug discovery and structural analysis of these G protein-coupled receptors.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Chemokine receptors CXCR4 and CCR5 are critical targets for various diseases, including HIV and cancer.
- Studying these G protein-coupled receptors (GPCRs) requires methods that preserve their native binding characteristics.
- Previous methods for studying receptor-ligand interactions often involved membrane-bound receptors, posing challenges for detailed biophysical and structural analysis.
Purpose of the Study:
- To develop and validate a biosensor assay using solubilized chemokine receptors CXCR4 and CCR5.
- To assess the binding affinity of natural ligands and small molecules to these receptors.
- To demonstrate the utility of solubilized receptors for kinetic characterization and structural studies.
Main Methods:
- Utilized Biacore technology for direct measurement of binding interactions.
- Solubilized chemokine receptors (CXCR4 and CCR5) from whole cell pellets.
- Captured solubilized receptors on antibody surfaces for biosensor analysis.
- Validated the assay using known ligands (SDF-1alpha, RANTES) and small molecule inhibitors (RCP-168, JM-2987, TAK-779).
Main Results:
- Solubilization conditions successfully maintained high-affinity binding of natural ligands to CXCR4 and CCR5.
- The biosensor assay demonstrated reliable binding responses for both chemokines and small molecule inhibitors.
- High-quality kinetic data were obtained for 19 novel small molecule inhibitors of CCR5, correlating with membrane-associated receptor values.
- Demonstrated the ability to collect binding responses for archetypal small molecule inhibitors.
Conclusions:
- Solubilized chemokine receptors CXCR4 and CCR5 retain their native binding properties.
- The developed biosensor-based method is effective for characterizing ligand and small molecule interactions with these receptors.
- These solubilized receptor preparations are valuable reagents for future biophysical and structural investigations of chemokine receptors.
Related Concept Videos
Ligand Binding Sites
14.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.8K
GPCR Desensitization
7.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.7K
GPCRs Regulate Adenylyl Cylase Activity
7.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.0K
G Protein-coupled Receptors
16.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.1K
Transducer Mechanism: G Protein–Coupled Receptors
3.6K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.6K